Long-term effects of delapril hydrochloride on procollagen type III amino-terminal peptide, left ventricular mass and left ventricular function in hypertensive patients

Japanese Circulation Journal

Volumn 62, Issue 12, 1998, Pages 900-902

  Matoba, Munetoshi ^a,c   Asaji, Takayoshi ^b   Matsui, Shinobu ^b   Takekoshi, Noboru ^b  

^a Matoba Hospital   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Delapril hydrochloride; Left ventricular mass; Procollagen type III amino terminal peptide

Indexed keywords

DELAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; LONG TERM CARE; MALE; ORAL DRUG ADMINISTRATION;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; INDANS; MALE; ORGAN SIZE; PEPTIDE FRAGMENTS; PROCOLLAGEN; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0031701104     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.900     Document Type: Article

References (28)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561-1566
2. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352
3. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-1865
4. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Mizuno T, et al: Mechanical stress activates protein kinase cascade of phosphorylation in neonatal rat cardiac myocytes. J Clin Invest 1995; 96: 438-446
5. Dahlöf B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110
6. Inada Y, Tanabe M, Shibouta Y, Kawazoe K, Nishikawa K, Kikuchi S: Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models. Jpn J Pharmacol 1986; 42: 1-8
7. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55: 613-618
8. Fogelman AM, Abbasi AS, Pearce ML, Kattus AA: Echocardiographic study of the abnormal motion of the posterior left ventricular wall during angina pectoris. Circulation 1972; 46: 905-913
9. Yoshida K, Akasaka T, Maeda K: Evaluation of cardiac function. In: Yoshikawa J, editor. Clinical echocardiography. Tokyo: Bunkodo, 1991: 218
10. Risteli L, Risteli J: Noninvasive methods for detection of organ fibrosis. In: Rojkind M, editor. Focus on connective tissue in health and disease. Boca Raton, FL: CRC Press, 1990: 61-98
11. Weber KT, Pick R, Jalil JE, Janicki JS, Carroll E: Patterns of myocardial fibrosis. J Mol Cell Cardiol 1989; 21: 121-131
12. Eghbali M, Blumenfeld OO, Seifter S, Buttrick PM, Leinwand LA, Robinson TF, et al: Localization of type I, III and IV collagen mRNAs in rat heart cells by in situ hybridization. J Mol Cell Cardiol 1989; 21: 103-113
13. Chapman D, Weber KT, Eghbali M: Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in hypertrophied rat myocardium. Circ Res 1990; 67: 787-794
14. Eghbali M, Tomek R, Sukhatme VP, Woods C, Bhambi B: Differential effects of transforming growth factor-β1 and phorbol myristate acetate on cardiac fibroblasts. Circ Res 1991; 69: 483-490
15. Yoshiyama M, Takeuchi K, Kim S, Hanatani A, Omura T, Toda I, et al: Effect of manidipine hydrochloride, a calcium antagonist, on isoproterenol-induced left ventricular hypertrophy. Jpn Circ J 1998; 62: 47-52
16. Laviades C, Mayor G, Diez J: Treatment with lisinopril normalizes serum concentrations of procollagen type III amino-terminal peptide in patients with essential hypertension. Am J Hypertens 1994; 7: 52-58
17. Eleftheriades EG, Durand JB, Ferguson AG, Engelmann GL, Jones SB, Samarel AM: Regulation of procollagen metabolism in the pressure-overload rat heart. J Clin Invest 1993; 91: 1113-1122
18. Brilla CG: The cardiac structure-function relationship and the reninangiotensin-aldosterone system in hypertension and heart failure. Curr Opin Cardiol 1994; 9(Suppl 1): S2-S11
19. Charney RH, Takahashi S, Zhao M, Sonnenblick EH, Eng C: Collagen loss in the stunned myocardium. Circulation 1992; 85: 1483-1490
20. Jensen LT, HØrslev-Petersen K, Toft P, Bentsen KD, Grande P, Simonsen EE, et al: Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction. Circulation 1990; 81: 52-57
21. Schuppan D: Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis. J Hepatol 1991; 13(Suppl 3): S17-S25
22. Low RB, Cutroneo KR, Davis GS, Giancola MS: Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis. Lab Invest 1983; 48: 755-759
23. Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, et al: Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 1993; 46: 32-36
24. Kono T, Taniguchi A, Imura H: Effects of a new angiotensin converting enzyme inhibitor, N-[N-{(S)-1-ethoxycarbonyl-3-phenyl-propyl}-L-alanyl]-N-(indan-2-yl) glycine hydrochloride (CV-3317) in normal men. Jpn Arch Intern Med 1984; 31: 63-69
25. Takeda N, Iwai T, Tanamura A, Nakamura I, Nagano M: Effects of delapril hydrochloride on the myocardium of spontaneously hypertensive rats. Can J Cardiol 1994; 10: 939-943
26. Tanaka K, Honda M, Kuramochi T, Hashimoto M, Masumura S, Mansoor AM, et al: Different effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on protein metabolism in rats with right ventricular hypertrophy. J Hypertens 1994; 12: 1147-1154
27. Shionoiri H, Yasuda G, Ikeda A, Ohta T, Miyajima E, Kaneko Y: Pharmacokinetics and depressor effect of delapril in patients with essential hypertension. Clin Pharmacol Ther 1987; 41: 74-79
28. Matsuzaki K, Mukai M, Sumimoto T, Murakami E: Effects of ACE inhibitors versus calcium antagonists on left ventricular morphology and function in patients with essential hypertension. Hypertens Res 1997; 20: 7-10